WHO ICTRP trial
Comparison of two doses of citrate in regional citrate anticoagulation during…
ACTRN12613001340729 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12613001340729 |
|---|---|
| Public title | Comparison of two doses of citrate in regional citrate anticoagulation during hemodialysis |
| Scientific title | Comparison of biocompatibility markers with two doses of citrate in regional citrate anticoagulation during hemodialysis |
| Primary sponsor | University Medical Center Ljubljana |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | Slovenia |
| Conditions | hemodialysis ;kidney disease; hemodialysis kidney disease;Renal and Urogenital - Kidney disease |
| Interventions | Single, 4 hour hemodialysis with regional citrate anticoagulation with citrate dose 60 mmol/h |
| Registration date | Sep 12, 2013 |
| Target size | 30 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: